- Consumer Products
- Latest 20.935
- Currency US$
- Change 0.205
- Percent Change 0.989 %
- Volume 85,425
- Wed May 22, 2013 11:54 AM EDT NYSE data delayed 15 minutes.
12 months ended Dec 31, 2012.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||May 13||$0.27||Aug 12||$0.34|
12 months ended May 22, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research- driven and customer-focused company, WuXi PharmaTech provides pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services throughout the drug discovery and development process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save its customers both time and money. Its operations are grouped into two segments: laboratory services, consisting of discovery chemistry, service biology, analytical, pharmaceutical development and process development services, and manufacturing, focusing on manufacturing of advanced intermediates and active pharmaceutical ingredients for R&D use.